Related references
Note: Only part of the references are listed.BMS-986205, an indoleamine 2, 3-dioxygenase 1 inhibitor (IDO1i), in combination with nivolumab (nivo): Updated safety across all tumor cohorts and efficacy in advanced bladder cancer (advBC).
Jason J. Luke et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
A phase II, randomized study of nivolumab (nivo) or nivo plus BMS-986205 with or without intravesical Bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, non-muscle invasive bladder cancer (NMIBC): CheckMate 9UT.
Noah M. Hahn et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Overexpression of Indoleamine 2,3-Dioxygenase 1 Promotes Epithelial-Mesenchymal Transition by Activation of the IL-6/STAT3/PD-L1 Pathway in Bladder Cancer
Wentao Zhang et al.
TRANSLATIONAL ONCOLOGY (2019)
Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis
Brian W. Labadie et al.
CLINICAL CANCER RESEARCH (2019)
Mass spectrometric measurement of urinary kynurenine-to-tryptophan ratio in children with and without urinary tract infection
Melanie L. Yarbrough et al.
CLINICAL BIOCHEMISTRY (2018)
Dysregulation of Tryptophan Catabolism in Metabolic Syndrome
Neila Hiraishi Mallmann et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2018)
Simultaneous determination of tryptophan and 8 metabolites in human plasma by liquid chromatography/tandem mass spectrometry
Lysiane Boulet et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
Guideline of guidelines: non-muscle-invasive bladder cancer
Solomon L. Woldu et al.
BJU INTERNATIONAL (2017)
Tryptophan Metabolism in Patients With Chronic Kidney Disease Secondary to Type 2 Diabetes: Relationship to Inflammatory Markers
Subrata Debnath et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2017)
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline
Sam S. Chang et al.
JOURNAL OF UROLOGY (2016)
Assessment of the Human Kynurenine Pathway: Comparisons and Clinical Implications of Ethnic and Gender Differences in Plasma Tryptophan, Kynurenine Metabolites, and Enzyme Expressions at Baseline and After Acute Tryptophan Loading and Depletion
Abdulla A. -B. Badawy et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2016)
Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
The Health Economics of Bladder Cancer: An Updated Review of the Published Literature
Christina Yeung et al.
PHARMACOECONOMICS (2014)
ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular Markers
Ashish M. Kamat et al.
EUROPEAN UROLOGY (2013)
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IDO Induces Expression of a Novel Tryptophan Transporter in Mouse and Human Tumor Cells
Jonathan D. Silk et al.
JOURNAL OF IMMUNOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Noninvasive Urinary Metabonomic Diagnosis of Human Bladder Cancer
Kishore Kumar Pasikanti et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?
Esther W. de Bekker-Grob et al.
BJU INTERNATIONAL (2009)
Recurrence and Progression of Disease in Non-Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
Bas W. G. van Rhijn et al.
EUROPEAN UROLOGY (2009)
Quality control in transurethral resection of bladder tumours
Harry W. Herr et al.
BJU INTERNATIONAL (2008)
Monitoring the response of orthotopic bladder tumors to granulocyte macrophage colony-stimulating factor therapy using the prostate-specific antigen gene as a reporter
QH Wu et al.
CLINICAL CANCER RESEARCH (2004)
Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients
JP Stein et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Share Paper
